Hims & Hers appoints former Robinhood exec Dheerja Kaur as first CPO

Published 26/06/2025, 16:30
© Reuters.

Investing.com -- Hims & Hers Health (NYSE:HIMS) has named Dheerja Kaur as its first-ever Chief Product Officer, according to an announcement from CEO Andrew Dudum.

Kaur joins the healthcare platform with nearly two decades of experience building consumer products. She previously served as VP of Product at Robinhood (NASDAQ:HOOD), where she led Robinhood Gold, a premium membership service that attracted over 3 million subscribers and contributed significantly to the company’s revenue growth.

Before her role at Robinhood, Kaur worked as Chief Product Officer at The Skimm, where she focused on redefining how millennial women access news across various media formats.

The appointment comes as Hims & Hers pursues global expansion, increases investments in artificial intelligence, and develops new offerings. Kaur will work alongside the company’s new CTO and engineering team to enhance provider-patient engagement and develop AI-powered tools across therapy, nutrition, and coaching services.

Dudum emphasized that Kaur’s leadership will be crucial in creating a more personalized healthcare experience that adapts to individual needs. Her appointment follows other recent leadership additions, including Mo Elshenawy and Nader Kabbani, as the company works to build a more accessible and affordable healthcare platform.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.